MENU
+Compare
PAHC
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$30.67
Change
+$0.10 (+0.33%)
Capitalization
1.24B

PAHC Phibro Animal Health Corp Forecast, Technical & Fundamental Analysis

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company... Show more

PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PAHC with price predictions
Aug 15, 2025

PAHC in +8.44% Uptrend, rising for three consecutive days on August 13, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PAHC advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on PAHC as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PAHC just turned positive on August 13, 2025. Looking at past instances where PAHC's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

PAHC moved above its 50-day moving average on August 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for PAHC moved out of overbought territory on August 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PAHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PAHC broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PAHC entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.673) is normal, around the industry mean (16.611). P/E Ratio (39.321) is within average values for comparable stocks, (72.068). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.758). Dividend Yield (0.016) settles around the average of (0.031) among similar stocks. P/S Ratio (1.047) is also within normal values, averaging (40.357).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PAHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PAHC is expected to report earnings to fall 17.46% to 51 cents per share on August 27

Phibro Animal Health Corp PAHC Stock Earnings Reports
Q2'25
Est.
$0.52
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
The last earnings report on May 07 showed earnings per share of 62 cents, beating the estimate of 52 cents. With 316.30K shares outstanding, the current market capitalization sits at 1.24B.
A.I.Advisor
published Dividends

PAHC paid dividends on June 25, 2025

Phibro Animal Health Corp PAHC Stock Dividends
А dividend of $0.12 per share was paid with a record date of June 25, 2025, and an ex-dividend date of June 04, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of animal health pharmaceutical and nutritional products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
300 Frank W. Burr Boulevard
Phone
+1 201 329-7300
Employees
1920
Web
https://www.pahc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNGRX25.630.07
+0.27%
Sit International Growth
DIVPX17.030.01
+0.06%
MAI Managed Volatility Investor
PRASX19.360.01
+0.05%
T. Rowe Price New Asia
MXKWX10.22-0.03
-0.29%
Empower S&P 500® Index Institutional
IPOAX21.36-0.07
-0.33%
Macquarie Systematic Em Mkts Eq A

PAHC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with AMRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+0.33%
AMRX - PAHC
47%
Loosely correlated
+0.64%
PBH - PAHC
45%
Loosely correlated
+0.60%
ZTS - PAHC
44%
Loosely correlated
+0.69%
ELAN - PAHC
40%
Loosely correlated
-0.22%
VTRS - PAHC
38%
Loosely correlated
-0.75%
More

Groups containing PAHC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+0.33%
Pharmaceuticals: Generic
industry (227 stocks)
12%
Poorly correlated
-1.78%